Market Cap ₹81 Cr.
Stock P/E 17.3
P/B 1.8
Current Price ₹49.4
Book Value ₹ 28.1
Face Value 10
52W High ₹110
Dividend Yield 0%
52W Low ₹ 45
Incorporated in 2005 and headquartered in Himatnagar, Gujarat, Dhanlaxmi Crop Science Ltd is a technology-driven seed company specializing in the development, production, processing, and marketing of seeds for a wide range of field crops and vegetables. The company integrates traditional breeding techniques with biotechnological tools to produce hybrid and open-pollinated varieties that offer higher yields, improved product quality, and enhanced tolerance to pests and diseases
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|
| Net Sales | 35 | 47 | 64 | |
| Other Income | 0 | 0 | 0 | |
| Total Income | 35 | 47 | 64 | |
| Total Expenditure | 34 | 42 | 57 | |
| Operating Profit | 2 | 5 | 7 | |
| Interest | 1 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | |
| Profit Before Tax | 1 | 4 | 6 | |
| Provision for Tax | 0 | 1 | 2 | |
| Profit After Tax | 1 | 3 | 5 | |
| Adjustments | 0 | 0 | 0 | |
| Profit After Adjustments | 1 | 3 | 5 | |
| Adjusted Earnings Per Share | 1.1 | 2.5 | 3.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 36% | 0% | 0% | 0% |
| Operating Profit CAGR | 40% | 0% | 0% | 0% |
| PAT CAGR | 67% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 34% | 26% | 26% | 26% |
| ROCE Average | 43% | 27% | 27% | 27% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| Shareholder's Funds | 6 | 11 | 16 |
| Minority's Interest | 0 | 0 | 0 |
| Borrowings | 5 | 2 | 1 |
| Other Non-Current Liabilities | 1 | 1 | 1 |
| Total Current Liabilities | 9 | 6 | 17 |
| Total Liabilities | 21 | 20 | 35 |
| Fixed Assets | 2 | 2 | 2 |
| Other Non-Current Assets | 0 | 0 | 0 |
| Total Current Assets | 19 | 18 | 33 |
| Total Assets | 21 | 20 | 35 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 3 |
| Cash Flow from Operating Activities | 2 | 6 | 0 |
| Cash Flow from Investing Activities | 0 | -0 | -0 |
| Cash Flow from Financing Activities | -1 | -5 | -2 |
| Net Cash Inflow / Outflow | 1 | 2 | -2 |
| Closing Cash & Cash Equivalent | 1 | 3 | 1 |
| # | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| Earnings Per Share (Rs) | 1.1 | 2.5 | 3.89 |
| CEPS(Rs) | 1.5 | 2.68 | 4.08 |
| DPS(Rs) | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 11.62 | 9.52 | 13.47 |
| Core EBITDA Margin(%) | 4.38 | 9.64 | 10.75 |
| EBIT Margin(%) | 3.78 | 9.24 | 10.45 |
| Pre Tax Margin(%) | 2.23 | 8.78 | 10.06 |
| PAT Margin (%) | 1.64 | 6.43 | 7.3 |
| Cash Profit Margin (%) | 2.25 | 6.89 | 7.67 |
| ROA(%) | 2.79 | 14.65 | 16.93 |
| ROE(%) | 9.44 | 34.1 | 33.82 |
| ROCE(%) | 8.76 | 29.41 | 42.77 |
| Receivable days | 87.94 | 67.51 | 50.55 |
| Inventory Days | 72.18 | 45.95 | 41.41 |
| Payable days | 26.48 | 14.34 | 6 |
| PER(x) | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.27 | 0.07 | 0.14 |
| EV/Core EBITDA(x) | 6.1 | 0.74 | 1.3 |
| Net Sales Growth(%) | 0 | 31.55 | 36.69 |
| EBIT Growth(%) | 0 | 221.16 | 54.65 |
| PAT Growth(%) | 0 | 413.98 | 55.35 |
| EPS Growth(%) | 0 | 128.08 | 55.35 |
| Debt/Equity(x) | 1.48 | 0.23 | 0.06 |
| Current Ratio(x) | 1.98 | 2.99 | 1.88 |
| Quick Ratio(x) | 1.24 | 2.2 | 1.32 |
| Interest Cover(x) | 2.44 | 20.28 | 26.72 |
| Total Debt/Mcap(x) | 0 | 0 | 0 |
| # | Mar 2025 |
|---|---|
| Promoter | 73.76 |
| FII | 5.93 |
| DII | 1.11 |
| Public | 19.2 |
| Others | 0 |
| Total | 100 |
| # | Mar 2025 |
|---|---|
| Promoter | 1.2 |
| FII | 0.1 |
| DII | 0.02 |
| Public | 0.31 |
| Others | 0 |
| Total | 1.63 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
